KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Capital Employed (2018 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Return on Capital Employed for 8 consecutive years, with 0.17% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 18.0% year-over-year to 0.17%, compared with a TTM value of 0.17% through Dec 2025, up 18.0%, and an annual FY2025 reading of 0.08%, up 9.0% over the prior year.
  • Return on Capital Employed was 0.17% for Q4 2025 at Teva Pharmaceutical Industries, up from 0.15% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.17% in Q4 2025 and bottomed at 0.09% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.01%, with a median of 0.01% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -11bps in 2022, then rose 18bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.05% in 2021, then tumbled by -244bps to 0.07% in 2022, then soared by 121bps to 0.01% in 2023, then crashed by -177bps to 0.01% in 2024, then surged by 1670bps to 0.17% in 2025.
  • Business Quant data shows Return on Capital Employed for TEVA at 0.17% in Q4 2025, 0.15% in Q3 2025, and 0.08% in Q2 2025.